Insitro - Manage Profile

Artificial Intelligence | Machine Learning | Natural Language Processing Insitro | Predictions for Drug Discovery and Development

South San Francisco, California, United States

Artificial Intelligence | Machine Learning | Natural Language Processing

Insitro | Predictions for Drug Discovery and Development

South San Francisco, California, United States

insitro is an exciting startup company that aims to take a new approach to drug development: one with big data and machine learning at its core.

B2C

51 to 100

Series B

$243M

Growth

2018

N/A

Yes

Active

   Machine Learning
   Natural Language Processing
   Knowledge Representation and Reasoning

TensorFlow

PyTorch

Caffe

Docker

Kubernetes

N/A

Software

Python

C++

Scala

APIs

SQL

NoSQL

AWS

GCP

Terraform

Hadoop

Spark

SLURM

Neural Networks

$400M

Company was founded 2018 and it took almost 3 years (Mar 2021) to raise first external round

Date

Round

$ Raised

Investors

03/15/2021

Series C

$400M

Two Sigma Ventures, T. Rowe Price, Third Rock Ventures, HOF Capital, GV, Foresite Capital, Canadian Pension Plan Investment Board, Casdin Capital, BlackRock Private Equity Partners,, ARCH Venture Partners, Andreessen Horowitz

Date : 03/15/2021

Round: Series C

$ Raised: $400M

Investors: Two Sigma Ventures, T. Rowe Price, Third Rock Ventures, HOF Capital, GV, Foresite Capital, Canadian Pension Plan Investment Board, Casdin Capital, BlackRock Private Equity Partners,, ARCH Venture Partners, Andreessen Horowitz

Investors

Interested in researching Insitro?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Insitro

Request a Demo - Deal Souring Platform

Daphne Koller
Founder and CEO

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Insitro

Insitro - Manage Profile